CommercialPrior AuthMedium impact
Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology, Pediatrics·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi updated their policy A.8.01.32 for hematopoietic cell transplantation (HCT) coverage in acute lymphoblastic leukemia patients. The policy specifies when autologous and allogeneic HCT procedures are considered medically necessary versus investigational, with prior authorization required through Case Management for all covered transplant procedures.
Action Required
Immediately: Billing team must ensure all hematopoietic cell transplantation procedures for acute lymphoblastic leukemia patients require prior authorization through Blue Cross Blue Shield of Mississippi Case Management before scheduling. Update system alerts to flag these cases. Claims will not be covered without prior authorization.